OYLER JOHN sold BGNE
October 8, 2024 · Form 4 insider transaction
OYLER JOHN sold 2,059 shares of BeiGene, Ltd. at $235.41 per share, a transaction worth $484.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each American Depositary Share represents 13 Ordinary Shares.; The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.01 to $235.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.; These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.